LSKL TFA, CAS [[2828433-17-4]]

Produktübersicht

• Artikelname: LSKL TFA, CAS [[2828433-17-4]]
• Artikelnummer: TGM-TP2147
• Hersteller Artikelnummer: TP2147
• Alternativnummer: TGM-TP2147-1MG,TGM-TP2147-5MG,TGM-TP2147-10MG,TGM-TP2147-25MG,TGM-TP2147-50MG,TGM-TP2147-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: H-Leu-Ser-Lys-Leu-NH2 TFA , LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA) , H-Leu-Ser-Lys-Leu-NH2 TFA(283609-79-0 TFA)

Produktbeschreibung

LSKL TFA (H-Leu-Ser-Lys-Leu-NH2 TFA) is a LAP-TGFbeta derivative and a TGF-beta1 antagonist that can cross the blood-brain barrier, inhibits the binding of TSP-1 to LAP and reduces renal interstitial fibrosis and liver fibrosis, inhibits subarachnoid fibrosis by inhibiting TSP-1-mediated TGF-beta1 activity, prevents the occurrence of chronic hydrocephalus and improves long-term neurocognitive deficits after subarachnoid hemorrhage.

Produkteigenschaften

• Molekulargewicht: 572.62
• Reinheit: 99.33%
• CAS Nummer: [2828433-17-4]
• Formel: C23H43F3N6O7
• Target-Kategorie: TGF-beta/Smad

Bilder

TP2147